NCT01601912

Brief Summary

The primary study aim is to unravel the nature of impaired pain inhibition during exercise in patients with chronic Whiplash-Associated Disorders (WAD). This will be ascertained by examining whether activation of serotonergic and/or noradrenergic descending pathways improves pain inhibition during exercise in these patients. In addition, it is aimed at examining whether activation of serotonergic and/or noradrenergic descending pathways prevents post-exertional malaise following submaximal exercise in chronic WAD patients. A secondary study aim comprises of examining the effect of an acute submaximal exercise with and without activation of serotonergic or noradrenergic descending pathways on chronic WAD patients' cognitive performance. Furthermore, the isolated effect of activated serotonergic and noradrenergic descending pathways on chronic WAD patients' cognitive performance will be studied.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 18, 2012

Completed
9 months until next milestone

Study Start

First participant enrolled

February 1, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

January 14, 2014

Status Verified

January 1, 2014

Enrollment Period

10 months

First QC Date

May 14, 2012

Last Update Submit

January 13, 2014

Conditions

Keywords

Whiplash InjuriesChronic PainExerciseCognition

Outcome Measures

Primary Outcomes (3)

  • Changes in pain inhibition

    To investigate pain inhibition, a combination of temporal en spatial summation will be used on the example of Cathcart et al. (2009). Temporal summation is applied by using an analogue Wagner pressure algometer and spatial summation is induced by causing ischemic pain with an inflatable cuff.

    Baseline before and after the submaximal graded exercise= day 1 A & B, after first intervention before and after the submaximal graded exercise= day 8 A & B, after second intervention before and after the submaximal graded exercise = day 15 A & B

  • Changes in psychomotor vigilance and alertness

    To investigate cognitive function we used the Psychomotor Vigilance Task (PVT) which is a 10-minute test.

    Baseline before and after the submaximal graded exercise= day 1 A & B, after first intervention before and after the submaximal graded exercise= day 8 A & B, after second intervention before and after the submaximal graded exercise = day 15 A & B

  • Changes in selective attention and executive function

    The Stroop task is used to assess selective attention and executive function

    Baseline before and after the submaximal graded exercise= day 1 A & B, after first intervention before and after the submaximal graded exercise= day 8 A & B, after second intervention before and after the submaximal graded exercise = day 15 A & B

Secondary Outcomes (3)

  • Change in scores on the Neck Disability Index questionnaire

    Baseline = day 1, after the first intervention = day 8, after the second intervention = day 15

  • Change in scores on the Brief Pain Inventory questionnaire

    Baseline = day 1, after the first intervention = day 8, after the second intervention = day 15

  • Changes in the scores on the Whiplash Associated Disorders Symptom list

    Day 1 pre and post submaximal graded exercise and 24h after exercise = day 1 A,B&C, day 8 pre and post submaximal graded exercise & 24h after exercise = day 8 A,B&C, day 15 pre and post submaximal graded exercise & 24h after exercise = day 15 A,B&C

Study Arms (2)

Atomoxetine NRI

We will modulate endogenous adrenergic pain inhibitory mechanisms by using a selective norepinephrine reuptake inhibitor (NRI).

Drug: Atomoxetine

Citalopram SSRI

We will modulate serotonergic pain inhibitory mechanisms by using a selective serotonin reuptake inhibitor (SSRI)

Drug: Citalopram

Interventions

40 mg, 1 application

Also known as: Strattera (Eli Lilly Nederland B.V)
Atomoxetine NRI

20 mg, 1 application

Also known as: Citalopram Sandoz (Sandoz N.V.)
Citalopram SSRI

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

WAD patients: primary care clinic \& community sample Healthy people: community sample

You may qualify if:

  • WAD grades I to III according to the Quebec Task Force criteria
  • experienced a whiplash trauma at least three months ago
  • with chronic pain as a result of a whiplash injury
  • years of age and with Dutch as their native language will be able to participate

You may not qualify if:

  • other comorbidities or health issues that could explain the pain complaints
  • \< 18years \> 65 years
  • pregnant or until 1 year postnatal (for women)
  • use of anti-depressive, anti-epileptic and pain medication.
  • years of age and with Dutch as their native language will be able to participate
  • having a sedentary job and doing \< 3 h moderate physical activity/week
  • being painfree without any chronic disease
  • \< 18years \> 65 years
  • pregnant or until 1 year postnatal (for women)
  • use of anti-depressive, anti-epileptic and pain medication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitair Ziekenhuis Brussel

Brussels, Brussels Capital, 1090, Belgium

Location

Related Publications (2)

  • Van Oosterwijck J, Nijs J, Meeus M, Van Loo M, Paul L. Lack of endogenous pain inhibition during exercise in people with chronic whiplash associated disorders: an experimental study. J Pain. 2012 Mar;13(3):242-54. doi: 10.1016/j.jpain.2011.11.006. Epub 2012 Jan 24.

    PMID: 22277322BACKGROUND
  • Ickmans K, Malfliet A, De Kooning M, Goudman L, Hubloue I, Schmitz T, Goubert D, Aguilar-Ferrandiz ME. Lack of Gender and Age Differences in Pain Measurements Following Exercise in People with Chronic Whiplash-Associated Disorders. Pain Physician. 2017 Sep;20(6):E829-E840.

MeSH Terms

Conditions

Whiplash InjuriesChronic PainMotor Activity

Interventions

Atomoxetine HydrochlorideCitalopram

Condition Hierarchy (Ancestors)

Neck InjuriesWounds and InjuriesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

PropylaminesAminesOrganic ChemicalsNitrilesBenzofuransHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Jo Nijs, PhD

    Vrije Universiteit Brussel

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc

Study Record Dates

First Submitted

May 14, 2012

First Posted

May 18, 2012

Study Start

February 1, 2013

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

January 14, 2014

Record last verified: 2014-01

Locations